+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

From
From
From
From
From
NASH Treatment & Therapeutics Market Report 2023-2033 - Product Thumbnail Image

NASH Treatment & Therapeutics Market Report 2023-2033

  • Report
  • July 2023
  • 224 Pages
  • Global
From
Liver Cancer Drugs Market 2025-2029 - Product Thumbnail Image

Liver Cancer Drugs Market 2025-2029

  • Report
  • April 2025
  • 236 Pages
  • Global
From
From
Liver Diseases Therapeutics Market - Global Forecast 2026-2030 - Product Thumbnail Image

Liver Diseases Therapeutics Market - Global Forecast 2026-2030

  • Report
  • January 2026
  • 184 Pages
  • Global
From
From
Ovulation Inducing Drugs Market Report 2026 - Product Thumbnail Image

Ovulation Inducing Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Integrase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Integrase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Fusion Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Fusion Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Translational Regenerative Medicine Market Report 2024-2034 - Product Thumbnail Image

Translational Regenerative Medicine Market Report 2024-2034

  • Report
  • February 2024
  • 270 Pages
  • Global
From
Vasculitis Treatment - Global Strategic Business Report - Product Thumbnail Image

Vasculitis Treatment - Global Strategic Business Report

  • Report
  • March 2026
  • 183 Pages
  • Global
From
Loading Indicator